Table 1. Differentially expressed miRNAs in CD19+ peripheral blood cells from lung cancer patients vs. healthy individuals.

CD19+ lymphocytes	median healthy donors	median LCa patients	ratio L/H	FC	P
hsa-miR-34a-5p	3.46	4.86	1.41	2.64	0.009
hsa-miR-148a-3p	4.63	5.93	1.28	2.47	0.031
hsa-miR-144-3p	5.67	3.60	0.63	0.24	0.003

Log-transformed normalized expression data originate from Leidinger et al., 2014 [23], LCa: lung cancer, FC: fold change, P: P-value.